Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,195 | 776 | 2,122 | 1,399 | 821 |
| Income taxes - deferred | 11 | -2 | 2 | N/A | N/A |
| Other Working Capital | 519 | 111 | 273 | 323 | 56 |
| Other Operating Activity | -2,452 | -1,179 | -3,635 | -2,502 | -1,546 |
| Operating Cash Flow | $-727 | $-294 | $-1,238 | $-780 | $-669 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 479 | 151 | 839 | 476 | 333 |
| Investing Cash Flow | $479 | $151 | $839 | $476 | $333 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -9 | -9 | -32 | -32 | -32 |
| Financing Cash Flow | $-9 | $-9 | $-32 | $-32 | $-32 |
| Beginning Cash Position | 1,658 | 1,658 | 2,090 | 2,090 | 2,090 |
| End Cash Position | 1,402 | 1,507 | 1,658 | 1,754 | 1,722 |
| Net Cash Flow | $-256 | $-152 | $-432 | $-336 | $-368 |
| Free Cash Flow | |||||
| Operating Cash Flow | -727 | -294 | -1,238 | -780 | -669 |
| Free Cash Flow | -727 | -294 | -1,238 | -780 | -669 |